Earlier, we demonstrated that treatment with a PI3K inhibitor triggers BAD dephosphorylation at S112 and S136; we also used shRNA knockdown to demonstrate that BAD is necessary for apoptosis induction by PI3K inhibitors in prostate cancer cells [20]. Here, BAD is linked to prostate carcinoma.